The US government’s COVID-19 vaccine purchasing agreement with Pfizer Inc. and BioNTech US is the highest such vaccine funding commitment to be announced yet, likely reflecting the fact that Pfizer is bearing all the risk for developing and manufacturing its candidate and the government does not have to.
Under an agreement announced on 22 July, the Health and Human Services Department’s Biomedical Advanced Research and Development Authority (BARDA)...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?